Chugai Now Takes Nissan Chemical to Court over Edirol Patent, Seeks Damages from Sawai, Nichi-Iko Too

November 30, 2020
Chugai Pharmaceutical has launched another patent lawsuit in Japan involving its osteoporosis treatment Edirol (eldecalcitol), this time bringing Nissan Chemical to court in an attempt to block its raw material production for the API eldecalcitol. In the suit filed with...read more